JNK modulators (Syndexa)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameJNK modulators (Syndexa)
Drug Alias Namec-Jun N-terminal kinase modulators (Syndexa)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionc-Jun N-terminal kinase modulators
Targetsc-Jun N-terminal kinase
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSyndexa Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSyndexa Pharmaceuticals Corp
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A